| Oct 7 |
Biodesix Announces New Data Presentation at CHEST 2024 Annual Meeting and the Launch of a Complementary Clinical Study
|
| Sep 5 |
Biodesix to Present at Two Investor Conferences in September
|
| Aug 10 |
Biodesix Second Quarter 2024 Earnings: Beats Expectations
|
| Aug 8 |
Q2 2024 Biodesix Inc Earnings Call
|
| Aug 8 |
Biodesix, Inc. (BDSX) Q2 2024 Earnings Call Transcript
|
| Aug 7 |
Biodesix, Inc. (BDSX) Reports Q2 Loss, Tops Revenue Estimates
|
| Aug 7 |
Biodesix GAAP EPS of -$0.08 beats by $0.01, revenue of $17.9M beats by $1.76M
|
| Aug 7 |
Biodesix Announces Second Quarter 2024 Results and Highlights
|
| Aug 6 |
Biodesix to Present at Canaccord Genuity’s 44th Annual Growth Conference
|
| Jul 24 |
Biodesix to Report Second Quarter 2024 Financial Results on August 7, 2024
|
